Federated Hermes’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$75.3K Sell
2,278
-559
-20% -$23.7K ﹤0.01% 1628
2025
Q4
$131K Buy
2,837
+1,965
+225% +$82.2K ﹤0.01% 1551
2025
Q3
$30.5K Buy
872
+350
+67% +$12.2K ﹤0.01% 1752
2025
Q2
$15.4K Sell
522
-79
-13% -$2.25K ﹤0.01% 1751
2025
Q1
$17.9K Sell
601
-2,466
-80% -$75.4K ﹤0.01% 1743
2024
Q4
$87.9K Sell
3,067
-327,426
-99% -$10.8M ﹤0.01% 1587
2024
Q3
$12.8M Buy
330,493
+1,027
+0.3% +$36.6K 0.03% 520
2024
Q2
$10.6M Sell
329,466
-65
-0% -$2.25K 0.03% 539
2024
Q1
$12.8M Buy
329,531
+116,763
+55% +$4.09M 0.03% 520
2023
Q4
$6.55M Buy
212,768
+91,911
+76% +$2.3M 0.02% 656
2023
Q3
$2.7M Buy
120,857
+18,464
+18% +$421K 0.01% 843
2023
Q2
$2.2M Buy
102,393
+29,223
+40% +$663K 0.01% 921
2023
Q1
$1.76M Buy
+73,170
New +$1.94M ﹤0.01% 999
2022
Q3
Sell
-9
Closed -$1K 2155
2022
Q2
$1K Sell
9
-262,095
-100% -$4.41M ﹤0.01% 2032
2022
Q1
$5.34M Sell
262,104
-232
-0.1% -$4.38K 0.01% 765
2021
Q4
$4.9M Buy
262,336
+69,781
+36% +$1.36M 0.01% 815
2021
Q3
$3.8M Buy
192,555
+20,951
+12% +$453K 0.01% 890
2021
Q2
$4.06M Buy
171,604
+171,379
+76,168% +$3.96M 0.01% 891
2021
Q1
$5K Sell
225
-3,826
-94% -$90.9K ﹤0.01% 2062
2020
Q4
$81K Sell
4,051
-31,134
-88% -$608K ﹤0.01% 1765
2020
Q3
$733K Sell
35,185
-93,017
-73% -$1.68M ﹤0.01% 1367
2020
Q2
$2.24M Sell
128,202
-130,270
-50% -$2.55M 0.01% 957
2020
Q1
$4.22M Buy
258,472
+95,210
+58% +$1.97M 0.01% 676
2019
Q4
$3.36M Buy
163,262
+83,572
+105% +$1.39M 0.01% 887
2019
Q3
$915K Buy
79,690
+66,315
+496% +$757K ﹤0.01% 1304
2019
Q2
$176K Buy
+13,375
New +$179K ﹤0.01% 1557
2018
Q4
Sell
-190
Closed -$3K 2210
2018
Q3
$3K Sell
190
-30
-14% -$532 ﹤0.01% 2106
2018
Q2
$5K Sell
220
-411
-65% -$10.1K ﹤0.01% 2011
2018
Q1
$16K Sell
631
-128
-17% -$3.05K ﹤0.01% 1798
2017
Q4
$14K Buy
+759
New +$10.9K ﹤0.01% 1823
2016
Q1
Sell
-192
Closed -$5K 2112
2015
Q4
$5K Buy
+192
New +$4.04K ﹤0.01% 1869

Other funds holding COLL